The Marie Skłodowska - Curie European Training Networks AEGIS and TASPPI are pleased to announce the common organized international conference New Frontiers in Structure-Based Drug Discovery, Sep 23-25, 2019 at Convitto della Calza in Florence, Italy.

Attracting a high-level audience of researchers, the conference will provide a stimulating platform to discuss with academic experts and scientists from biotech and pharmaceutical industries. Topics include innovative screens on protein-protein interactions, novel targets and target validation, structure-based drug discovery, computational approaches and more. The conference will provide a valuable platform to discuss the challenges and opportunities of modern drug discovery in academia and industry.

Already since the times of Leonardo da Vinci, Florence provides with his vibrating scientific and cultural environment  an excellent framework for the valuable experience of collaboration and scientific exchange reaching out to junior investigators and leading scientists in the field of drug research.

In order to foster interaction and discussions in the field, we are pleased to host an exceptional group of internationally renowned experts on the topic of drug discovery, who build the framework of the New Frontiers in Structure-based Drug Discovery's scientific program.

Additional oral presentations will be selected from submitted abstracts at New Frontiers in Structure-Based Drug Discovery.
A poster session will provide opportunities for further discussions.

 

Registration deadline:    July 31, 2019                          Deadline for abstracts:    June 30, 2019

 

Speakers (confirmed):

Patrizia	Aducci	Università di Roma	Italy
Michelle	Arkin	University of California San Francisco	United States
Alessio	Ciulli	University of Dundee	United Kingdom
Steve	Fesik	Vanderbilt University	United States
Mike	Hann	GlaxoSmithKline	United Kingdom
Birthe	Kragelund	University of Copenhagen	Denmark
Ora	Schueler-Furman	Hebrew University	Israel
Jan	Steyaert	VIB	Belgium
Ed	Tate	Imperial College London	United Kingdom
Rebecca	Wade	HITS gGmbH, Heidelberg University	Germany

 

Organization Committee:

Michael Sattler, Eva Schlosser (both Helmholtz Zentrum München), Christian Ottmann (University of Eindhoven), Michael Nilges (Institut Pasteur), Gerhard Klebe (Philipps-Universität Marburg), Wolfgang Jahnke (Novartis), Alex Dömling (University of Groningen),  Matteo Gentili and Laura Bassani (both Giotto Biotech)

 

The conference New Frontiers in Structure-based Drug Discovery as well as the programs AEGIS and TASPPI are funded by the EU Horizon 2020 (2014–2020) framework program under the Marie Skłodowska-Curie Grant Agreement no. 675555, AEGIS and Grant Agreement no. 675179, TASPPI.